Abstract
For hematopoietic stem cell transplantation (HCT) HLA 10/10 (HLA-A, B, C, DRB1, DQB1) matched donors are optimal, but are not available for all patients. The identification of permissive/non-immunogenic mismatches may improve the outcome of HLA mismatched transplants. We hypothesize that HLA alleles identical within the antigen recognition domain (ARD), but mismatched outside the peptide binding groove or α-helices are often permissive mismatches. We evaluated the functional impact of non-ARD mismatches by performing in vitro functional T cell assays. Cytotoxic T Lymphocyte precursor assays were performed for 23 HLA class I mismatches and 96% (22 out of 23) were negative. Mixed lymphocyte reaction assays were conducted on 10 HLA class II mismatches and all were negative. However, 4 out of 10 combinations were positive in the Elispot and all involved one direction: a DRB1*14:01/DRB3*02:01 responder against a DRB1*14:54/DRB3*02:02 stimulator. These positive responses were confirmed by Primed Lymphocyte Testing and the DRB1* mismatch seemed to be responsible for the response. In conclusion, HLA mismatches with amino-acid differences outside the ARD are not very immunogenic. However, in some cases weak T cell reactivity in vitro can be observed. The impact of these responses on clinical outcome of HCT remains to be established.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sj Lee, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High resolution donor–recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–83.
Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood. 2014;124:2596–606.
Hou L, Vierra-Green C, Lazaro A, Brady C, Haagenson M, Spellman S, Hurley CK, Limited HLA. sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor–recipient pairs. HLA. 2017;89:39–46.
Xiao Y, Lazaro AM, Masaberg C, Haagenson M, Vierra-Green C, Spellman S, et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hemapoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens. 2009;73:595–8.
Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE. IMGT/HLA database–a sequence database for the human major histocompatibility complex. Tissue Antigens. 2000;55:280–7. www.ebi.ac.uk/imgt/hla
Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T, Zhang R, et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci USA. 2001;98:10799–804.
Gans CP, Tang TF, Slack R, Ng J, Hartzman RJ, Hurley CK. DRB1*14 diversity and DRB3 associations in four major population groups in the United States. Tissue Antigens. 2002;59:364–9.
Emmery P, Mach B, Reith W. The different level of expression of HLA-DRB1 and –DRB3 genes is controlled by conserved isotopic differences in promotor sequence. Hum Immunol. 1993;38:137–47.
Zhang L, FPMJ VanBree, Van Rood, Claas JJ. FHJ. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors. Transplantation. 1990;50:1008–10.
Strijbosch LWG, Buurman WA, Does RJMM, Zinken PH, Groenewegen G. Limiting dilution analysis. Experimental design and statistical analysis. J Immunol Methods.1987;97:133–40.
Mickelson EM, Clift RA, Fefer A, Storb R, Thomas ED, Warren RP, et al. Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings. Transplantation. 1981;32:90–95.
van Els CA, Bakker A, van Rood JJ, Goulmy E. Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell. Hum Immunol. 1990;28:39–50.
Oudshoorn M, Doxiadis II, van den Berg-Loonen PM, Voorter CE, Verduyn W, Claas FH. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing? Hum Immunol. 2002;63:176–84.
Fernandez-Viña MA, Wang T, Lee SJ, et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014;123:1270–8.
Bettens F, Schanz U, Tiercy J-M. Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+alloreactive T lymphocytes: the HLA-B44 paradigm. Tissue Antigens. 2013;81:414–8.
Heeger PS. “T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant. 2003;3:525–33.
Faner R, James E, Huston L, Pujol-Borrel R, Kwok WW, Juan M. Reassessing the role of HLA-DRB3 T cell responses: evidence for significant expression and complementary antigen presentation. Eur J Immunol. 2010;40:91–102.
Van Balen P, van Luxemburg-Heijs SA, van de Meent M, van Bergen CA, Halkes CJ, Jedema I, Falkenburg JH. Mismatched HLA-DRB3 can induce a potent immune response after HLA 10/10 matched stem cell transplantation. Transplantation. 2017 https://doi.org/10.1097/TP.0000000000001713.
Pasi A, Crocchiolo R, Bontempelli M, Carcassi C, Carella G, Crespiatico L, et al. The conundrum of HLA DRB1*14:01/*14:54 and HLA-DRB3*02:01/02:02 mismatches in unrelated hematopoietic SCT. Bone Marrow Transplant. 2011;46:916–22.
Acknowledgements
The CIBMTR is supported by Office of Naval Research Grants N00014-14-1-0028 and N00014-15-1-0848. The views expressed in this article do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or any other agency of the US government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Roelen, D., de Vaal, Y., Vierra-Green, C. et al. HLA mismatches that are identical for the antigen recognition domain are less immunogenic. Bone Marrow Transplant 53, 729–740 (2018). https://doi.org/10.1038/s41409-018-0108-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-018-0108-6